首页> Medical journal of the Islamic Republic of Iran> The Impact of Adding Prandial Insulin to a Basal Based Regimen with Insulin Glargine in Type 2 Diabetic Patients.

The Impact of Adding Prandial Insulin to a Basal Based Regimen with Insulin Glargine in Type 2 Diabetic Patients.

导出 OA

翻译打印收藏纠错

第一作者： Mohammad Ebrahim,Khamseh

第一单位： Endocrine Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Tehran, Iran.

作者： Mohammad Ebrahim,Khamseh ^[1] ; Zahra,Abbasi Ranjbar ^[2] ; Zahra,Banazadeh ^[3] ; Mani,Mirfeizi ^[4] ; Manouchehr,Mohammadbeiki ^[5] ; Zohreh,Mozafari ^[6] ; Kamnoosh,Razazian ^[7] ; Mojtaba,Malek ^[8]

作者单位： Endocrine Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Tehran, Iran. ^[1] Razi Hospital, Guilan University of Medical Sciences, Rasht, Iran. ^[2] Lolagar Hospital, Iran University of Medical Sciences, Tehran, Iran. ^[3] Department of Midwifery, College of Nursing & Midwifery, Karaj Branch, Islamic Azad University, Karaj, Iran. ^[4] Prevention of Metabolic Disorders Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran. ^[5] Sanofi Iran, Tehran, Iran. ^[6] Sohrabi Clinic, Tehran, Iran. ^[7] Research Center for Prevention of Cardiovascular Disease, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Tehran, Iran. ^[8]

关键词 Diabetes Mellitus type 2 Glycated Hemoglobin A Insulin, Short-Acting Safety Treatment Outcome

DOI 10.47176/mjiri.35.177

PMID 35685198

发布时间 2023-09-16

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交